Some companies are being paid a premium to keep their medicines on the PBS and well supplied while others are having their prices slashed to the point they are exiting the program. Is anyone else confused? And, why Ernest Hemingway provides the best metaphor for how people should approach the period ahead - the fisherman, the marlin and the sharks.

Latest Video
New Stories
-
Island Pharmaceuticals reports breakthrough survival data for galidesivir in Marburg and Ebola studies
September 17, 2025 - - Australian Biotech -
Australian Dementia Network Registry wants access to 'turning point' therapies
September 17, 2025 - - Latest News -
Pharmac proposes funding new ADHD medicine to tackle supply shortages
September 17, 2025 - - Latest News -
New data reveals deep inequities as Sanofi rolls out trust-building initiative
September 17, 2025 - - Latest News -
Ipsen appoints Dagmar Tschoep as general manager for Australia and New Zealand
September 16, 2025 - - Latest News -
Merck welcomes new director of market access, government affairs and communications
September 16, 2025 - - Latest News -
New mental health service takes aim at the silent struggle of undiagnosed ADHD
September 16, 2025 - - Latest News